Evidence map›Paper›PMID 41763441›Full record

ReviewBiological psychiatry2026

Multimodal Representation Learning for Parsing Biological Heterogeneity in Psychiatric Neuroimaging.

Logan Grosenick, Conor Liston

Abstract readReview
In one paragraph

Review in Biological psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Logan GrosenickDepartment of Psychiatry and Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York. Electronic address: log4002@med.cornell.edu.
Conor ListonDepartment of Psychiatry and Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York. Electronic address: col2004@med.cornell.edu.

Funding

Efficacy of biomarker-guided rTMS for treatment resistant depressionR01MH118388 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI BHATI, MAHENDRA T, GUNNING, FAITH M · 2019 to 2025
$6.2M
Regulation of prefrontal cortical circuit function and reward-seeking behavior by stress-induced dendritic spine remodelingR01MH118451 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI Joshua Levitz, Conor M Liston · 2019 to 2026
$5.5M
Reproducibility statistics and machine learning methods for systematic phenotyping and model integration across animals, organs, and technologiesR01OD039830 · OD · WEILL MEDICAL COLL OF CORNELL UNIV · PI GROSENICK, LOGAN · 2025 to 2025
$3.3M
Scalable Biomarkers and Generative Digital Twins for Personalized Neurostimulation in DepressionR01MH131534 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI LOGAN GROSENICK · 2022 to 2026
$3.2M
Biomarker-Guided Antidepressant Selection for Treatment-Resistant DepressionUG3MH137656 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI LISTON, CONOR M, MURROUGH, JAMES WARREN · 2024 to 2024
$1.4M
NIH HHS R01 OD039830NIMH NIH HHS R01 MH118388NIMH NIH HHS R01 MH118451NIMH NIH HHS R01 MH131534NIMH NIH HHS UG3 MH137656
6 · The paper itself

Abstract

For decades, psychiatric neuroimaging has searched for biomarkers of depression and other disorders, but they remain elusive in clinical practice. While the last 5 years have seen rapid progress, other large-scale correlative studies have found only small, unreliable links between brain measures and clinical symptoms. Growing evidence suggests that such limitations are not just about sample size but depend critically on how models represent data. This review traces a recent shift away from univariate methods to multivariate/multiview approaches that learn more effective representations of biological and symptom measures by flexibly learning multimodal latent representations. First, we review how linear multiview embedding methods have revealed reproducible biological depression subtypes but do not perform well in small samples or samples enriched for mild symptoms. Then, we consider newer work exploring more sophisticated representations for neuroimaging data, including deep-learning and graph-based representations, and multimodal extensions that uncover complex latent patterns that single-modality studies miss. Then, we review recent developments in foundation models, which, once trained on large corpora, can "transfer learn" readily to small clinical cohorts, potentially bringing the advantages of large-scale learning to small, privacy-limited data. Finally, we highlight emerging representation tools that treat the brain as a dynamic, stateful multivariate process. Taken together, these advances point to a future in which the value of neuroimaging will be determined not only by ever-larger sample sizes but also by data quality and by how well our algorithms capture the distributed, multimodal, and evolving nature of psychiatric disorders.

Indexed as

BrainMental DisordersNeuroimagingHumansRepresentation Machine LearningBiomarkersComputational psychiatryDepressionfMRIHeterogeneity

Identifiers

PMID41763441
PMCPMC13241018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.